Rimonabant: obituary for a wonder drug.
paper
Cited
Public
Unavailable
- Authors
- Boekholdt, S Matthijs; Peters, Ron J G
- Year
- 2010
- Journal
- Lancet (London, England)
- PMID
- 20709215
- DOI
- 10.1016/S0140-6736(10)61080-X
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| The Role of Fatty Acid Binding Proteins in Neuropsychiatric Diseases: A Narrative Review. | Powell A et al. | — | 2025 | → |
| Exploring the association between suicidal thoughts, self-injury, and GLP-1 receptor agonists in weight loss treatments: Insights from pharmacovigilance measures and unmasking analysis. | Guirguis A et al. | — | 2024 | → |
| G protein-coupled receptors and obesity. | Pocai A | — | 2023 | → |
| Unexpected short- and long-term effects of chronic adolescent HU-210 exposure on emotional behavior. | Farinha-Ferreira M et al. | — | 2022 | → |
| Unexpected short- and long-term effects of chronic adolescent HU-210 exposure on emotional behavior | Farinha-Ferreira M et al. | — | 2021 | — |
| Cannabinoid Receptors: An Update on Cell Signaling, Pathophysiological Roles and Therapeutic Opportunities in Neurological, Cardiovascular, and Inflammatory Diseases. | Haspula D et al. | — | 2020 | → |
| Cannabinoid Actions on Neural Stem Cells: Implications for Pathophysiology. | Rodrigues RS et al. | — | 2019 | → |
| Kinetics of human cannabinoid 1 (CB1) receptor antagonists: Structure-kinetics relationships (SKR) and implications for insurmountable antagonism. | Xia L et al. | — | 2018 | → |
| Structure-Affinity Relationships and Structure-Kinetic Relationships of 1,2-Diarylimidazol-4-carboxamide Derivatives as Human Cannabinoid 1 Receptor Antagonists. | Xia L et al. | — | 2017 | → |
| New Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline? | Beard E et al. | — | 2016 | → |
| Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysis. | Carey CE et al. | — | 2015 | → |
| Arachidonoyl ethanolamide (AEA)-induced apoptosis is mediated by J-series prostaglandins and is enhanced by fatty acid amide hydrolase (FAAH) blockade. | Kuc C et al. | — | 2012 | → |
| Co-occurrence of diabetes and depression: conceptual considerations for an emerging global health challenge. | Fisher EB et al. | — | 2012 | → |
| Drug treatment of obesity in cardiovascular disease. | Charakida M et al. | — | 2012 | → |
| Cannabinoid 1 G protein-coupled receptor (periphero-)neutral antagonists: emerging therapeutics for treating obesity-driven metabolic disease and reducing cardiovascular risk. | Janero DR et al. | — | 2011 | → |
| Differential pattern of response in mood symptoms and suicide risk measures in severely ill depressed patients assigned to citalopram with placebo or citalopram combined with lithium: role of lithium levels. | Khan A et al. | — | 2011 | → |